A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

To evaluate the tolerance, and comparative virologic and immunologic effects of the two combination regimens.

N/A

Bristol-Myers Squibb

Indinavir
Lamivudine
Stavudine
Zidovudine